skip to main content

British experts discredit 'complete the course' advice on antibiotics

Around 700,000 people worldwide die annually due to drug-resistant infections
Around 700,000 people worldwide die annually due to drug-resistant infections

A team of British experts have cast doubt on medical advice that a course of prescribed antibiotics should be taken in its entirety to be effective.

Experts writing in The British Medical Journal argue that the warning given to patients at the start of treatment is not supported by the evidence.

They argue that patients are put at unnecessary risk from antibiotic resistance when treatment is given for longer than necessary, not when it is stopped early.

Professor Martin Llewelyn at Brighton and Sussex Medical School and colleagues say that traditionally antibiotics are prescribed for recommended treatment courses and fundamental to this concept is the notion that a shorter treatment would be more inferior.

They add that for most indications, studies to identify the minimum effective treatment duration simply have not been performed.

The "complete the course" notion ignores the fact that different patients respond to treatments in different ways, they said.

"Currently, we largely ignore this fact and instead make indication specific recommendations for antibiotic duration that are based on poor evidence.

"This situation is changing in hospital practice, where biomarkers of treatment response can guide when to stop antibiotic treatment.

"Outside hospital, where repeated testing may not be feasible, patients might be best advised to stop treatment when they feel better, in direct contradiction of WHO advice."

For common bacterial infections no evidence exists that stopping antibiotic treatment early increases a patient's risk of resistant infection, the experts said.

Reducing unnecessary antibiotic use is essential to mitigate antibiotic resistance, they argued, adding that antibiotics are a "precious and finite natural resource" which should be given to each patient with a tailored treatment duration.

They say research is needed to determine the most appropriate simple alternative messages, such as "stop when you feel better".

Commenting on the paper, spokesman for the Royal Pharmaceutical Society and consultant pharmacist Dr Kieran Hand, said: "This opinion article from respected NHS infection experts is a welcome opening of the debate in the UK on the relationship between the length of a course of antibiotics, efficacy and resistance.

"As the researchers have pointed out, further research is needed before the 'finish the course' mantra for antibiotics is changed and any alternative message such as 'stop when you feel better' can be confidently advocated."

If antibiotics lose their effectiveness, then key medical procedures - including gut surgery, caesarean sections, joint replacements and chemotherapy - could become too dangerous to perform.

Around 700,000 people around the world die annually due to drug-resistant infections such as TB, HIV and malaria.